Suvaxyn MH-One Slovenia - English - HMA (Heads of Medicines Agencies)

suvaxyn mh-one

pfizer gmbh - mycoplasma hyopneumoniae 1 rp - suspension for injection - pigs food - mycoplasma vaccine

Suvaxyn MH-One United Kingdom - English - HMA (Heads of Medicines Agencies)

suvaxyn mh-one

pfizer gmbh - mycoplasma hyopneumoniae 1 rp - suspension for injection - pigs food - mycoplasma vaccine

BOVI-SHIELD MH-ONE MANNHEIMIA HAEMOLYTICA VACCINE FOR CATTLE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bovi-shield mh-one mannheimia haemolytica vaccine for cattle

zoetis australia pty ltd - mannheimia haemolytica strain nl 1009 - misc. vaccines or anti sera - mannheimia haemolytica strain nl 1009 vaccine-general active 2.0 ml/do - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - respiratory disease | skin lesion

COOPERS BOVILIS MH + IBR BOVINE RESPIRATORY DISEASE (BRD) VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

coopers bovilis mh + ibr bovine respiratory disease (brd) vaccine

intervet australia pty limited - inactivated bovine herpes virus type 1.2b; inactivated mannheimia haemolytica strain x387; inactivated m. haemolytica leucotoxin strain x332 - misc. vaccines or anti sera - inactivated bovine herpes virus type 1.2b vaccine-viral active 0.0 m org/ml; inactivated mannheimia haemolytica strain x387 vaccine - general active 0.0 m org/ml; inactivated m. haemolytica leucotoxin strain x332 vaccine - general active 1.0e8 orgs/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine herpesvirus | bovine respiratory disease | shipping fever

BIOTIS HI-LOAD HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

biotis hi-load herbicide

biotis life science pty ltd - glyphosate present as the potassium salt - aqueous concentrate - glyphosate present as the potassium salt glycine active 540.0 g/l - herbicide - adzuki beans - pre-harvest | agricultural area - general | agricultural/farm buildings | avocado | banana | blueberry | chickpea - african lovegrass | african turnip weed | amaranth or amaranthus | amsinckia | annual grass weed | annual ground cherry | annual phalaris | annual ryegrass | annual weeds | artichoke thistle | bamboo | barley grass | barnyard grass or water grass | bathurst burr | bent grass - agrostis spp. | bitou bush or boneseed | blackberry | bladder ketmia | blady grass | boggabri weed | boxthorn | bracken | broadleaf weeds | brome grass | button grass | calomba daisy | caltrop or yellow vine | camel or afghan melon | canary grass | capeweed | carpet grass | cat's ear or flatweed | caustic weed | chickweed | chinese scrub | climbing buckwheat | cobbler's pegs | cocksfoot | columbus grass | couch | crofton weed | deadnettle | dock - seedling | english couch or rope twitch | erodium spp. | eucalyptus - seedling up to 2 m tall | fumitory | furze or gorse | giant or black pigweed | grain sorghum - post harvest | grain sorghum - pre harvest | ground cherry - physalis angulata | groundsel bush | guinea grass | hawthorn | hedge

COOPERS BOVILIS MH MANNHEIMIA HAEMOLYTICA VACCINE FOR CATTLE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

coopers bovilis mh mannheimia haemolytica vaccine for cattle

intervet australia pty limited - inactivated mannheimia haemolytica strain x387; inactivated m. haemolytica leucotoxin strain x332; polymyxin b sulfate; thiomersal - parenteral liquid/solution/suspension - inactivated mannheimia haemolytica strain x387 vaccine - general active 0.0 p; inactivated m. haemolytica leucotoxin strain x332 vaccine - general active 0.0 p; polymyxin b sulfate antibiotic other 0.1 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - respiratory disease

SUVAXYN MH - ONE VACCINE (INACTIVATED) Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

suvaxyn mh - one vaccine (inactivated)

virbac (australia) pty ltd - mycoplasma hyopneumoniae - inactivated antigen; thiomersal - parenteral liquid/solution/suspension - mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 0.0 ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pig - adult - lung lesions | mycoplasma hyopneumoniae | reduction of lung lesions | respiratory disease | swine enzootic pneumonia

RESPISURE MH/HPS VACCINE (INACTIVATED) Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

respisure mh/hps vaccine (inactivated)

zoetis - vaccine - mycoplasma hyopneum.+vaccine - glassers - parenteral liquid/solution/suspension - vaccine - pigs | boar | gilt | piglet | sow | swine - glassers disease | growth suppression | haemophilus parasuis serovar 13 | haemophilus parasuis serovar 4 | haemophilus parasuis serovar 5 | lung lesions | mycoplasma hyopneumoniae | polyserositis | respiratory disease | reduction of lung lesions | respiratory disease | swine enzootic pneumonia

NUFARM MH TOBACCO GROWTH RETARDANT Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm mh tobacco growth retardant

nufarm australia limited - maleic hydrazide as potassium salt - plant regulator - tobacco - burley | tobacco flue cured - sucker control | control of suckers

MULTIHANCE Israel - English - Ministry of Health

multihance

dexcel ltd, israel - gadobenic acid as dimeglumine salt - solution for injection - gadobenic acid as dimeglumine salt 334 mg/ml - gadobenic acid - gadobenic acid - multihance is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (mri) indicated for: • mri of the liver for the detection of focal liver lesions in patients with known or suspected primary liver cancer (eg. hepatocellular carcinoma) or metastatic disease.• mri of the brain and spine where it improves the detection of lesions and provides diagnostic information additional to that obtained with unenhanced mri.• contrast-enhanced mr- angiography where it improves the diagnostic accuracy for detecting clinically significant steno-occlusive vascular disease in patients with suspected or known vascular disease of the abdominal or peripheral arteries.• mri of the breast, for the detection of malignant lesions in patients where breast cancer is known or suspected on the basis of previous mammography or ultrasound results